DPP4 and glomerulosclerosis: Liu et al. showed that the DPP-4 inhibitor LAF237 reduced albuminuria, interstitial expansion, glomerulosclerosis, and the thickening of the glomerular basement membrane in STZ-induced diabetic rats.